
Release date: 2026-07-01 14:53:01 Article From: Lucius Laos Recommended: 21
Lemborexant may cause two relatively rare but alarming side effects. One is sleep paralysis, which is a brief (lasting a few minutes) inability to move or speak during falling asleep or waking up, with conscious awareness but loss of body control. Although it usually resolves on its own, it can still cause intense anxiety. The other is sudden leg weakness, which can occur at night or during the day, presenting as knee buckling or falls, resembling cataplexy. Both phenomena are related to the drug's modulation of arousal signals. If they occur for the first time, stay calm, inform your doctor, and record the frequency and triggering conditions. The doctor may suggest dose adjustment or discontinuation. However, note that these side effects do not affect the overall safety profile, and most patients will not experience them. Yet once they occur, it is essential to seek medical attention promptly and not ignore them.
More serious side effects include complex sleep behaviors—patients engage in sleepwalking, sleep driving, preparing and eating food, making phone calls, having sexual intercourse, etc., while not fully awake, with no memory of the event the next day. These behaviors may endanger the patient or others. Once detected, the drug should be stopped immediately and the doctor contacted. In addition, lemborexant may worsen depressive symptoms or trigger suicidal thoughts, especially in those with a history of mood disorders. If mood deterioration, increased anxiety, impulsive behavior, or suicidal ideation occurs during use, seek emergency help. Beyond these severe reactions, the most common adverse effect is daytime somnolence, which has a higher incidence but is mostly mild to moderate. Other occasional side effects include headache, dizziness, nausea, etc., but they are generally tolerable.
If you are considering lemborexant, it is recommended that you proactively discuss sleep issues with your doctor at your next visit. Prepare a personal insomnia log, including time to fall asleep, number of nighttime awakenings, daytime fatigue level, etc., to help your doctor make a precise assessment. You can also download and fill out the official discussion guide, which summarizes key medical history questions to improve communication efficiency. Additionally, the pharmaceutical company offers patient support services, including medication guidance, savings offers, and sharing of real patient stories, to help you gain a more comprehensive understanding of the treatment process. Any treatment decision should be a joint process between you and your doctor; do not hesitate to ask questions, such as dependency risk, duration of treatment, discontinuation methods, etc. If new symptoms appear or existing symptoms worsen, provide timely feedback. Through adequate communication, you can maximize the benefits of lemborexant while minimizing risks.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:[list:visits]2024-09-07
With generic drugs as its core, Laos' pharmaceutical industry has formed an industrial pattern f···【more】
Recommended:[list:visits]2026-02-07
The pharmaceutical industry in Laos started late and is limited in scale, with domestic drug supply ···【more】
Recommended:[list:visits]2026-01-07
Lucius Pharmaceuticals (Lao) Co., Ltd is a Lao pharmaceutical company established in 2020, headquart···【more】
Recommended:[list:visits]2026-30-06
The Lao generic pharmaceutical industry has developed rapidly in recent years, attracting increasing···【more】
Recommended:[list:visits]2026-29-06
Laos; pharmaceutical industry is relatively limited in scale, and domestic drug supply has long reli···【more】
Recommended:[list:visits]2026-26-06
MONDAY, June 15, 2026 — A study published online June 8 in Nature Medicine has found that apitegroma···【more】
Recommended:[list:visits]2026-24-06

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643